PTSD Seen in Nearly 20 Percent of Young Children With Cancer

This article originally appeared here.
PTSD Seen in Nearly 20 Percent of Young Children With Cancer
PTSD Seen in Nearly 20 Percent of Young Children With Cancer

(HealthDay News) -- Nearly 20 percent of infants and preschoolers with cancer suffer from posttraumatic stress disorder (PTSD), according to a study published online Aug. 22 in Psycho-Oncology.

Anna Graf, M.D., of University Children's Hospital Zurich, and colleagues conducted a study involving 48 patients with cancer, aged 8 to 48 months, to assess the prevalence of PTSD and to identify determinants. The patients were assessed in an average of 15 months after diagnosis, with mothers serving as informants and completing questionnaires, including the Posttraumatic Stress Disorder Semi-Structured Interview and Observational Record for Infants and Young Children.

The researchers found that 18.8 percent of children met the age-appropriate criteria for full PTSD, and 41.7 percent met the criteria for partial PTSD. Higher child age at diagnosis (odds ratio, 1.11) and maternal PTSD severity (odds ratio, 1.14) correlated with increased risk of full or partial PTSD in children, based on multivariate analysis.

"Our study provides crucial information on PTSD and its determinants in infants and preschoolers with cancer," the authors write. "Our findings confirm the need for careful, developmentally sensitive evaluations of PTSD in young pediatric cancer patients and their parents."

Full Text (subscription or payment may be required)

Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs